Press Release
Babbily Releases Its First Trained AI Model, Mochi, Redefining Web Search
The launch of Mochi marks a significant expansion of Babbily's capabilities. Mochi intelligently processes and synthesizes vast amounts of web data with superior precision, ensuring users receive the most relevant, well-grounded information at record speeds. Read More
Press Release
Nixxy's Auralink AI Enters Multi-Billion Dollar Telecom and Data Sectors
● Enters a Fast-Growing Business Sector with a Primary $15 Billion TAM and 19% CAGRs ● Expects its Disruptive Digital Telecom Software and Services Business Revenue to Accelerate in 2025 and Beyond ● Company Initially Targets $5 Million Monthly Revenue Run Rate for Q2 and $10 Million Monthly Revenue Run Rate in Q3 Read More
Press Release
Protagonist Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
$165.0 million icotrokinra (formerly JNJ-2113) milestone earned in Q4 2024, received in January 2025 PN-881, a potential best-in-class oral IL-17 receptor antagonist peptide nominated as a development candidate in Q4 2024 Topline results for rusfertide Phase 3 VERIFY clinical trial in polycythemia vera expected in March 2025 Topline results for icotrokinra Phase 2b ANTHEM clinical trial in moderate to severe ulcerative colitis expected in March 2025 Cash, cash equivalents, and marketable securities of $559.2 million as of December 31, 2024, combined with $165.0 million milestone payment, anticipated to provide cash runway through at least end of 2028 Read More
Press Release
Prolocor to Present New Clinical Evidence at ACC 25 Supporting Use of PLATELET FCɣRIIA (PFCG) As Key Tool In Individualizing Dual Antiplatelet Therapy (DAPT)
Date: March 31, 2025, 10:36 A.M. Location: Moderated Poster Theater 7 PROGNOSTIC IMPLICATIONS OF PLATELET FCÉ£RIIA DURING THE FIRST YEAR AFTER MYOCARDIAL INFARCTION Read More
Press Release
